Search

Your search keyword '"Kirk, Judy"' showing total 501 results

Search Constraints

Start Over You searched for: Author "Kirk, Judy" Remove constraint Author: "Kirk, Judy"
501 results on '"Kirk, Judy"'

Search Results

1. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

2. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia

4. BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry

5. The impact of coding germline variants on contralateral breast cancer risk and survival

6. Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial

9. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

11. DNA Mismatch Repair Gene Variant Classification: Evaluating the Utility of Somatic Mutations and Mismatch Repair Deficient Colonic Crypts and Endometrial Glands

12. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer

13. Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing

14. Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

15. Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset

16. Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers

17. Genotype--phenotype correlations in paediatric and adolescent phaeochromocytoma and paraganglioma: a cross-sectional study.

18. Cancer Risks Associated With TP53 Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum.

21. Parents’ expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial

22. Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma

26. Supplementary materials (clean version) from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public

27. Personalised risk booklet - an example from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public

30. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

34. What’s in a Name? Parents’ and Healthcare Professionals’ Preferred Terminology for Pathogenic Variants in Childhood Cancer Predisposition Genes

35. Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

37. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

42. Which Test Is Best? A Cluster-Randomized Controlled Trial of a Risk Calculator and Recommendations on Colorectal Cancer Screening Behaviour in General Practice

43. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence

44. Rare germline copy number variants (CNVs) and breast cancer risk

45. Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer

46. What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 12 months after premenopausal risk-reducing salpingo-oophorectomy

48. Communicating Personal Melanoma Polygenic Risk Information: Participants' Experiences of Genetic Counseling in a Community-Based Study.

49. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

50. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

Catalog

Books, media, physical & digital resources